183 related articles for article (PubMed ID: 30130654)
1. AML-associated mutation of nucleophosmin compromises its interaction with nucleolin.
Šašinková M; Holoubek A; Otevřelová P; Kuželová K; Brodská B
Int J Biochem Cell Biol; 2018 Oct; 103():65-73. PubMed ID: 30130654
[TBL] [Abstract][Full Text] [Related]
2. Nucleophosmin in leukemia: Consequences of anchor loss.
Brodská B; Šašinková M; Kuželová K
Int J Biochem Cell Biol; 2019 Jun; 111():52-62. PubMed ID: 31009764
[TBL] [Abstract][Full Text] [Related]
3. Localization of AML-related nucleophosmin mutant depends on its subtype and is highly affected by its interaction with wild-type NPM.
Brodská B; Kráčmarová M; Holoubek A; Kuželová K
PLoS One; 2017; 12(4):e0175175. PubMed ID: 28384310
[TBL] [Abstract][Full Text] [Related]
4. Low-Dose Actinomycin-D Induces Redistribution of Wild-Type and Mutated Nucleophosmin Followed by Cell Death in Leukemic Cells.
Brodská B; Holoubek A; Otevřelová P; Kuželová K
J Cell Biochem; 2016 Jun; 117(6):1319-29. PubMed ID: 26505272
[TBL] [Abstract][Full Text] [Related]
5. Nucleolar phosphoprotein modifications as a marker of apoptosis induced by RITA treatment.
Wolfová K; Otevřelová P; Holoubek A; Brodská B
Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119501. PubMed ID: 37276927
[TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.
Falini B; Mecucci C; Tiacci E; Alcalay M; Rosati R; Pasqualucci L; La Starza R; Diverio D; Colombo E; Santucci A; Bigerna B; Pacini R; Pucciarini A; Liso A; Vignetti M; Fazi P; Meani N; Pettirossi V; Saglio G; Mandelli F; Lo-Coco F; Pelicci PG; Martelli MF;
N Engl J Med; 2005 Jan; 352(3):254-66. PubMed ID: 15659725
[TBL] [Abstract][Full Text] [Related]
7. Nucleolar localization of aprataxin is dependent on interaction with nucleolin and on active ribosomal DNA transcription.
Becherel OJ; Gueven N; Birrell GW; Schreiber V; Suraweera A; Jakob B; Taucher-Scholz G; Lavin MF
Hum Mol Genet; 2006 Jul; 15(14):2239-49. PubMed ID: 16777843
[TBL] [Abstract][Full Text] [Related]
8. The roles of nucleolin subcellular localization in cancer.
Berger CM; Gaume X; Bouvet P
Biochimie; 2015 Jun; 113():78-85. PubMed ID: 25866190
[TBL] [Abstract][Full Text] [Related]
9. Heterozygous
Sheikh TI; Harripaul R; Vasli N; Ghadami M; Santangelo SL; Ayub M; Sasanfar R; Vincent JB
Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052391
[TBL] [Abstract][Full Text] [Related]
10. Leukemia-Associated Mutations in Nucleophosmin Alter Recognition by CRM1: Molecular Basis of Aberrant Transport.
Arregi I; Falces J; Olazabal-Herrero A; Alonso-Mariño M; Taneva SG; Rodríguez JA; Urbaneja MA; Bañuelos S
PLoS One; 2015; 10(6):e0130610. PubMed ID: 26091065
[TBL] [Abstract][Full Text] [Related]
11. Nucleolin and nucleophosmin: nucleolar proteins with multiple functions in DNA repair.
Scott DD; Oeffinger M
Biochem Cell Biol; 2016 Oct; 94(5):419-432. PubMed ID: 27673355
[TBL] [Abstract][Full Text] [Related]
12. [Features of the Structure and Expression of NPM and NCL Genes in Cutaneous Melanoma].
Ponkratova DA; Lushnikova AA
Mol Biol (Mosk); 2019; 53(4):663-673. PubMed ID: 31397440
[TBL] [Abstract][Full Text] [Related]
13. Nucleophosmin and its AML-associated mutant regulate c-Myc turnover through Fbw7 gamma.
Bonetti P; Davoli T; Sironi C; Amati B; Pelicci PG; Colombo E
J Cell Biol; 2008 Jul; 182(1):19-26. PubMed ID: 18625840
[TBL] [Abstract][Full Text] [Related]
14. RNA-recognition motifs and glycine and arginine-rich region cooperatively regulate the nucleolar localization of nucleolin.
Okuwaki M; Saotome-Nakamura A; Yoshimura M; Saito S; Hirawake-Mogi H; Sekiya T; Nagata K
J Biochem; 2021 Feb; 169(1):87-100. PubMed ID: 32785674
[TBL] [Abstract][Full Text] [Related]
15. [Nucleophosmin mutations in hematological malignancies - review].
Luo ZP; Zhang L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):662-6. PubMed ID: 17605889
[TBL] [Abstract][Full Text] [Related]
16. Recognition of intermolecular G-quadruplexes by full length nucleophosmin. Effect of a leukaemia-associated mutation.
Bañuelos S; Lectez B; Taneva SG; Ormaza G; Alonso-Mariño M; Calle X; Urbaneja MA
FEBS Lett; 2013 Jul; 587(14):2254-9. PubMed ID: 23742937
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia.
Falini B; Martelli MP; Bolli N; Bonasso R; Ghia E; Pallotta MT; Diverio D; Nicoletti I; Pacini R; Tabarrini A; Galletti BV; Mannucci R; Roti G; Rosati R; Specchia G; Liso A; Tiacci E; Alcalay M; Luzi L; Volorio S; Bernard L; Guarini A; Amadori S; Mandelli F; Pane F; Lo-Coco F; Saglio G; Pelicci PG; Martelli MF; Mecucci C
Blood; 2006 Sep; 108(6):1999-2005. PubMed ID: 16720834
[TBL] [Abstract][Full Text] [Related]
18. Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML.
Falini B; Bolli N; Shan J; Martelli MP; Liso A; Pucciarini A; Bigerna B; Pasqualucci L; Mannucci R; Rosati R; Gorello P; Diverio D; Roti G; Tiacci E; Cazzaniga G; Biondi A; Schnittger S; Haferlach T; Hiddemann W; Martelli MF; Gu W; Mecucci C; Nicoletti I
Blood; 2006 Jun; 107(11):4514-23. PubMed ID: 16455950
[TBL] [Abstract][Full Text] [Related]
19. Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor protein.
den Besten W; Kuo ML; Williams RT; Sherr CJ
Cell Cycle; 2005 Nov; 4(11):1593-8. PubMed ID: 16205118
[TBL] [Abstract][Full Text] [Related]
20. Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype.
Boissel N; Renneville A; Biggio V; Philippe N; Thomas X; Cayuela JM; Terre C; Tigaud I; Castaigne S; Raffoux E; De Botton S; Fenaux P; Dombret H; Preudhomme C
Blood; 2005 Nov; 106(10):3618-20. PubMed ID: 16046528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
